PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 117.0

(0.86%)

Revenue Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual revenue in 2023 was 18.03 Million TWD , up 5.11% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly revenue in 2024 Q1 was 4.99 Million TWD , up 46.21% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported a annual revenue of 17.15 Million TWD in annual revenue 2022, up 22.75% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported a annual revenue of 13.97 Million TWD in annual revenue 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly revenue of 4.99 Million TWD for 2024 Q1, up 46.21% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly revenue of 4.55 Million TWD for 2023 Q3, down -8.7% from previous quarter.

Annual Revenue Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Historical Annual Revenue of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Revenue Revenue Growth
2023 18.03 Million TWD 5.11%
2022 17.15 Million TWD 22.75%
2021 13.97 Million TWD 0.0%

Peer Revenue Comparison of PELL Bio-Med Technology Co. Ltd.

Name Revenue Revenue Difference
Apex Biotechnology Corp. 1.67 Billion TWD 98.924%
Sinphar Pharmaceutical Co.,Ltd. 2.96 Billion TWD 99.391%
Panion & Bf Biotech Inc. 1.88 Billion TWD 99.042%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 2.08 Billion TWD 99.136%
GenMont Biotech Incorporation 318.01 Million TWD 94.33%
Abnova (Taiwan) Corporation 382.05 Million TWD 95.28%
Adimmune Corporation 1.78 Billion TWD 98.99%
Tanvex BioPharma, Inc. 61.41 Million TWD 70.636%
Polaris Group 7.48 Million TWD -141.051%
Energenesis Biomedical CO.,LTD. 7.15 Million TWD -151.928%
UnicoCell Biomed Co., Ltd. 24.58 Million TWD 26.662%